Los Angeles, California

Friday, 13 December 2019 9:00 AM - 3:30 PM PST

8555 Beverly Boulevard, Los Angeles, California, 90048, United States

Register Now


Sale ended

MD Partial Approval - Free

sales ended

PA Partial Approval - Free

Sale ended

NP Partial Approval - Free

sales ended

RN Partial Approval - Free

Sale ended

Allied Health Professional/Other Partial Approval - Free

sales ended

MD/DO Fellow or Resident Partial Approval - Free

Sale ended

DO Partial Approval - Free

Enter your discount code

  • Fee
  • Total amount

1. Select Seats

2. Review and Proceed

Friday, 13 December 2019 9:00 AM - 3:30 PM PST

Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, California, 90048, United States.

Please note - a separate email address is required for each medical professional attending the program.

PHA Preceptorship Program: A Collaborative Approach for Clinicians on the Front Line

Sofitel Los Angeles at Beverly Hills
Sunset/Hollywood Rooms
8555 Beverly Boulevard
Los Angeles, California

9:00 - 9:30 AM

9:30 AM - Noon
Overview of Pulmonary Hypertension: Epidemiology and Pathophysiology
Aaron S. Weinberg, MD
Diagnosis and Assessment of Pulmonary Hypertension
Michael I. Lewis, MD
Selection of Appropriate Therapy
Rajan Sagar, MD

Noon - 1:00 PM

1:00 - 3:30 PM
Chronic Thromboembolic Pulmonary Hypertension
Richard N. Channick, MD, FCCP
Pulmonary Hypertension Due to Left Heart Disease
Antoine Hage, MD, FACC
Case Presentations and Discussion
Dael R. Geft, MD, FACC, Wendy M. Hill, MSN, NP-C, RN,and Siddharth Singh, MD, MS, with Victor F. Tapson, MD, FCCP, FRCP, Moderating

Preceptorship Faculty
From Cedars-Sinai Medical Center

Victor F. Tapson, MD, FCCP, FRCP, Moderator
Professor of Medicine
Director, Venous Thromboembolism and Pulmonary Vascular Disease Research Program
Director, Clinical Research, Women's Guild Lung Institute
Associate Director, Pulmonary and Critical Care Medicine

Dael R. Geft, MD, FACC
Smidt Heart Institute

Antoine Hage, MD, FACC
Professor of Medicine
Director, Solid Organ Transplant Cardiology
Co-Director, Pulmonary Hypertension Program
Smidt Heart Institute

Wendy M. Hill, MSN, NP-C
Nurse Practitioner and Coordinator
Pulmonary Hypertension Program

Michael I. Lewis, MD
Professor of Medicine
Director, Respiratory Care Services
Associate Director, Pulmonary Hypertension Program
Women's Guild Lung Institute

With Visiting Faculty From the David Geffen School of Medicine at UCLA
Ronald Reagan UCLA Medical Center

Richard N. Channick, MD, FCCP
Professor of Medicine
Co-Director, Pulmonary Vascular Disease Program
Director, Acute and Chronic Thromboembolic Disease Program

Rajan Saggar, MD
Associate Professor of Medicine
Director, Medical Intensive Care Unit
Co-Director, Pulmonary Vascular Disease Program
Director, Pulmonary Hypertension Program
Lung & Heart-Lung Transplantation Program

A complimentary lunch will be provided.

To comply with the Sunshine Act, when a meal is provided, physicians will be asked for their National Provider Identification (NPI) and state license number at registration.


Target Audience
This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with pulmonary arterial hypertension (PAH).

Educational Objectives
The PHA Preceptorship Program is designed to improve competence, performance, and patient care practices by instructing front-line clinicians in the highest quality of case for patients with PAh by combining didactic discourse and highly interactive case-based discussion. At the conclusion of this program, participants should be able to:

  • Define key pathophysiologic and epidemiologic components of PAh
  • Accurately diagnose patients through comprehensive screening and early recognition of symptoms
  • Evaluate the patient's condition and prescribe optimal long-term management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
  • Tailor comprehensive care for complex patient populations

In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for This Activity
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Statement
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, that planners, faculty and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest prior to the educational activity. Faculty must also disclose any planned discussion of unlabled/unapproved uses of drugs or devices during their presentation. Detailed disclosures will be made in activity handout materials.


Preceptorship Medical Education Program Committee Members
Jean M. Elwing, MD, FCCP (Committee Chair), University of Cincinnati College of Medicine; Eric D. Austin, MD, MSCI, Vanderbilt University School of Medicine; Christopher F. Barnett, MD, MPH, MedStar Washington Hospital Center; Kelly Chin, MD, MSCS, University of Texas Southwestern Medical Center; Lorinda Chung, MD, MS, Stanford University School of Medicine; Richard A. Krasuski, MD, FACC, FAHA, FESC, Duke University School of Medicine; Gustavo A. Heresi, MD, MS, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Tim Lahm, MD, Indiana University School of Medicine; Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP (Advisor), Michigan Medicine

Washington University School of Medicine in St. Louis, CME Reviewers
Murali M. Chakinala, MD, FCCP — Content
Allyson R. Zazulia, MD — CME

This activity is supported by educational grants from:

Diamond Level
Actelion Pharmaceuticals US, Inc.

Gold Level
United Therapeutics Corporation


Cancellation policy

Please let us know if you are unable to attend.

The Pulmonary Hypertension Association is committed to providing clinicians and researchers in the field with the most current information on pulmonary hypertension and raising awareness about this challenging disease. One way that we do this is through our medical education programming. For more information about our programs for medical professionals, please visit PHAssociation.org/Education-Programs/MedicalProfessionals

Contact the Organizer